|
Abohabib, 2018 [10]
|
Egypt
|
RCT
|
15 participants; -; 20.9 ± 3.4 years
|
30 OMI; 1.5 mm diameter and 8 mm length; maxilla; IL (150 g)
|
L group; C group
|
Stability: RFA using the Osstell ISQ device. Clinical success/failure rates: absence/presence of mobility.
|
10 weeks
|
|
Ekizer, 2016 [14]
|
Turkey
|
RCT
|
20 participants; 13 F/7 M; 16.77 ± 1.41 years
|
20 OMI; 1.6 mm diameter and 8 mm length; maxilla; -
|
L group; C group
|
Stability: RFA using the Osstell ISQ device. Inflammation: interleukin-1β levels in gingival and peri-implant crevicular fluid
|
3 months
|
|
Flieger, 2019
|
Poland
|
RCT
|
20 participants; 13 F/7M; 32.5 ± 6.1 years
|
40 OMI; 1.4 mm diameter and 10 mm length; maxilla; -.
|
L group; C group
|
Stability: PTV using the Periotest device. Pain: NRS-11
|
60 days
|
|
Marañón-Vásquez, 2019 [6]
|
Brazil
|
Non-RCT
|
19 participants; -; -
|
48 OMI for stability; 35 OMI for displacement; 1.5 mm diameter and 8 mm length; maxilla/mandible; IL/DL (150 g)
|
PBM + IL group; PBM + DL group; IL group/DL group
|
Stability: RFA using the Osstell ISQ device. Displacement: Images from CBCT
|
3 months
|
|
Matys, 2020 [16]
|
Poland
|
RCT
|
22 participants; 14 F/8 M; 31.7 ± 9.7 years
|
44 OMI; 1.4 mm diameter and 10 mm length; maxilla; -
|
L group; C group
|
Stability: PTV using the Periotest device. Pain: NRS-11
|
60 days
|
|
Osman, 2017 [15]
|
Egypt
|
RCT
|
12 participants; 6 F/6 M; 14 to 28 years
|
24 OMI; -; maxilla; DL (150 g)
|
L group; C group
|
Stability: PTV using the Periotest device. Inflammation: gingival index
|
60 days
|
